Neuroendocrine tumors (NETs) are a group of cancers that begin in the neuroendocrine cells of the body. These rare tumors can develop in tissues and organs that are part of the endocrine (hormone) system such as the lungs, stomach, intestines, pancreas, and liver. For many years, treatment options for NETs were limited. However, in recent times significant progress has been made in developing new targeted therapies and personalized treatment approaches.
